These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27684296)

  • 1. Determination of Colistin and Colistimethate Levels in Human Plasma and Urine by High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Bihan K; Lu Q; Enjalbert M; Apparuit M; Langeron O; Rouby JJ; Funck-Brentano C; Zahr N
    Ther Drug Monit; 2016 Dec; 38(6):796-803. PubMed ID: 27684296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate.
    Mercier T; Tissot F; Gardiol C; Corti N; Wehrli S; Guidi M; Csajka C; Buclin T; Couet W; Marchetti O; Decosterd LA
    J Chromatogr A; 2014 Nov; 1369():52-63. PubMed ID: 25441071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry.
    Gobin P; Lemaître F; Marchand S; Couet W; Olivier JC
    Antimicrob Agents Chemother; 2010 May; 54(5):1941-8. PubMed ID: 20176909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of polymixin B1, B2, ile-B1, E1, and E2 in human plasma and its clinical pharmacokinetic application.
    Xiang D; Li N; Yang G; Yu H; Li X; Qiu L; Chen Y; Liu L; Gong X
    J Pharm Biomed Anal; 2024 Nov; 250():116403. PubMed ID: 39116583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry.
    Tsai IL; Sun HY; Chen GY; Lin SW; Kuo CH
    Talanta; 2013 Nov; 116():593-603. PubMed ID: 24148450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of colistin A and colistin B in human plasma by UPLC-ESI high resolution tandem MS: application to a pharmacokinetic study.
    Gikas E; Bazoti FN; Katsimardou M; Anagnostopoulos D; Papanikolaou K; Inglezos I; Skoutelis A; Daikos GL; Tsarbopoulos A
    J Pharm Biomed Anal; 2013 Sep; 83():228-36. PubMed ID: 23764659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a UHPLC-MS/MS assay for colistin methanesulphonate (CMS) and colistin in human plasma and urine using weak-cation exchange solid-phase extraction.
    Zhao M; Wu XJ; Fan YX; Guo BN; Zhang J
    J Pharm Biomed Anal; 2016 May; 124():303-308. PubMed ID: 26970986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of colistin A/B and colistin methanesulfonate in biological samples using hydrophilic interaction chromatography tandem mass spectrometry.
    Qi B; Gijsen M; Van Brantegem P; De Vocht T; Deferm N; Abza GB; Nauwelaerts N; Wauters J; Spriet I; Annaert P
    Drug Test Anal; 2020 Aug; 12(8):1183-1195. PubMed ID: 32336034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel method for determination of colistin sulfate in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its clinical applications in critically ill patients.
    Wang X; Sun Q; Li X; Wang G; Xing B; Li Z
    J Pharmacol Toxicol Methods; 2024; 127():107502. PubMed ID: 38555058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of UPLC-MS/MS method for the determination of colistin in plasma and kidney and its application in pharmacokinetics.
    Wang Y; Yu X; Chen C; Zhang X; Ye Z; Yang J; Chen Y; Xiang Z; Lin G; Zhou Z
    J Pharm Biomed Anal; 2023 Sep; 233():115440. PubMed ID: 37150054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of UHPLC-MS/MS methods for the quantification of colistin in plasma and dried plasma spots.
    Cangemi G; Barco S; Castagnola E; Tripodi G; Favata F; D'Avolio A
    J Pharm Biomed Anal; 2016 Sep; 129():551-557. PubMed ID: 27505127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of colistin in human plasma, urine and other biological samples using LC-MS/MS.
    Ma Z; Wang J; Gerber JP; Milne RW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 862(1-2):205-12. PubMed ID: 18187372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantitation of polymyxin B1, polymyxin B2 and polymyxin B1-1 in human plasma and treated human urine using solid phase extraction and liquid chromatography-tandem mass spectrometry.
    Meng M; Wang L; Liu S; Jaber OM; Gao L; Chevrette L; Reuschel S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():23-36. PubMed ID: 26803416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS.
    Jansson B; Karvanen M; Cars O; Plachouras D; Friberg LE
    J Pharm Biomed Anal; 2009 Apr; 49(3):760-7. PubMed ID: 19157746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of cefadroxil in rat plasma and urine using LC-MS/MS and its application to pharmacokinetic and urinary excretion studies.
    Jin HE; Kim IB; Kim YC; Cho KH; Maeng HJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():103-10. PubMed ID: 24412692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of cefdinir levels in rat plasma and urine by high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral and intravenous administration of cefdinir.
    Jin HE; Kim IB; Kim CK; Maeng HJ
    Biomed Chromatogr; 2013 Nov; 27(11):1423-30. PubMed ID: 23712418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High performance liquid chromatography-mass spectrometry assay for polymyxin B1 and B2 in human plasma.
    Thomas TA; Broun EC; Abildskov KM; Kubin CJ; Horan J; Yin MT; Cremers S
    Ther Drug Monit; 2012 Aug; 34(4):398-405. PubMed ID: 22735673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
    Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of urinary metabolites as biomarkers of colistin-induced nephrotoxicity in rats by a liquid chromatography/mass spectrometry-based metabolomics approach.
    Jeong ES; Kim G; Moon KS; Kim YB; Oh JH; Kim HS; Jeong J; Shin JG; Kim DH
    Toxicol Lett; 2016 Apr; 248():52-60. PubMed ID: 26947560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Simple and Robust Liquid Chromatography With Tandem Mass Spectrometry Analytical Method for Therapeutic Drug Monitoring of Plasma and Cerebrospinal Fluid Polymyxin B1 and B2.
    Wang P; Zhang Q; Qin Z; Xing H; Xu M; Pei H; Yang J; Zhang X
    Ther Drug Monit; 2020 Oct; 42(5):716-723. PubMed ID: 32941397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.